Diagnostic home kit to detect midkine level in blood
Excellent valorization potential
- ✓First mover advantage — no home midkine kit on the market
- ✓Scientifically validated biomarker for multi-cancer detection
- ✓20-50x cost reduction vs. laboratory alternatives
- ✓Recent patent (2024) — strong protection for 18+ years
- ✓Missing software component = immediate opportunity
📋Executive Summary
This patent describes a home diagnostic kit using a cantilever biosensor to measure midkine levels in blood — a key biomarker for early detection of multiple cancers (lung, liver, colorectal). The invention holds a major competitive advantage: no direct competitor offers a home-based solution for midkine detection. The Point-of-Care cancer diagnostics market is estimated at $5.8B in 2026.
⚙️Key Technical Points
- Cantilever biosensor with anti-midkine antibody layer
- Integrated signal processor + output display unit
- Quantitative biomarker detection in <15 minutes
- Works on capillary blood sample (finger prick)
- No sample preparation required (sample-to-answer)
🎯Competitive Intelligence
| Competitor | Method | Price | Location | Exploitable weakness |
|---|---|---|---|---|
| Grail (Galleri Test) | Multi-cancer cfDNA analysis | $949/test | Lab only | No midkine, not home-based, high cost |
| Agilent Technologies | Cantilever AFM (research) | N/A (R&D) | Laboratory | Professional equipment, not consumer |
| ELISA Standard | Enzyme-linked immunoassay | $200-500/test | Certified lab | Slow (4-6h), technician required, expensive |
| OraSure Technologies | Home test HIV/HCV | $40-80/test | Home | No cancer biomarker, no midkine |
→ Conclusion: Your patent has no direct competitor in the home-based midkine segment. You have a significant first mover advantage.
📊Market Size
💡3 Software Valorization Opportunities
Patient Companion App
A mobile application allowing patients to scan their results, track their midkine level history, and share data with their doctor. Includes alerts when threshold is exceeded.
Clinician Dashboard
A web interface for physicians to visualize their patients' results from the kit, with history, trends, and automatic alerts.
Investor Landing Page
A professional presentation page with an interactive ROI calculator comparing kit cost vs. standard ELISA. Enables pitching during fundraising or licensing discussions.
Interested in a prototype?
We can develop a working prototype of opportunity #1 (Companion App) in 48 hours, ready to show investors or licensees.